| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2021 | PRIVO TECHNOLOGIES, INC. | 200 CORPORATE PLACESUITE6B | PEABODY | MA | 01960 | ESSEX | USA | Food and Drug Administration Research | 000 | 3 | 11/14/2022 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $99,660 ) |
| 2021 | 2021 | PRIVO TECHNOLOGIES, INC. | 200 CORPORATE PLACESUITE6B | PEABODY | MA | 01960 | ESSEX | USA | Food and Drug Administration Research | 000 | 3 | 6/30/2021 | NON-COMPETING CONTINUATION | $99,660 |
|
| Issue Date FY: 2020 ( Subtotal = $498,400 ) |
| 2020 | 2020 | PRIVO TECHNOLOGIES, INC. | 200 CORPORATE PLACESUITE6B | PEABODY | MA | 01960 | ESSEX | USA | Food and Drug Administration Research | 000 | 2 | 6/25/2020 | NON-COMPETING CONTINUATION | $498,400 |
|
| Issue Date FY: 2019 ( Subtotal = $449,307 ) |
| 2019 | 2019 | PRIVO TECHNOLOGIES, INC. | 200 CORPORATE PLACESUITE6B | PEABODY | MA | 01960 | ESSEX | USA | Food and Drug Administration Research | 000 | 1 | 9/5/2019 | NEW | $449,307 |
|
|